# NobelZygoma TiUltra Implant System Study

> **NCT07258940** · NA · NOT_YET_RECRUITING · sponsor: **Nobel Biocare** · enrollment: 85 (estimated)

## Conditions studied

- Edentulous Maxilla
- Maxillary Bone Loss
- Atrophic Maxilla

## Interventions

- **DEVICE:** NobelZygoma™ 0° CC TiUltra™implant ; NobelZygoma™ 45° Ext Hex TiUltra™ implant
- **DEVICE:** Multi-Unit Abutment Xeal Zygoma Ext Hex RP; 17° Multi-Unit Abutment Xeal Zygoma Ext Hex RP; 45° Multi.Unit Abutment Xeal Zygoma CC RP; 60° Multi-Unit Abutment Xeal Zygoma CC RP

## Key facts

- **NCT ID:** NCT07258940
- **Lead sponsor:** Nobel Biocare
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2028-11-01
- **Final completion:** 2029-11-01
- **Target enrollment:** 85 (ESTIMATED)
- **Last updated:** 2025-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07258940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07258940, "NobelZygoma TiUltra Implant System Study". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT07258940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*